Pacira Pharmaceuticals Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (24)

View All

Latest Posts

About This Stock More About This Stock
Bear Market Bets In Biotech
Article By: MoneyShow.com
Monday, February 7, 2022 9:44 AM EDT
Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.
In this article: ACAD, BMRN, CLDX, INCY, PCRX, IONS, MDGL, MYOV
Read
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Article By: Benzinga
Monday, October 11, 2021 3:48 PM EDT
Toward the end of trading on Monday, the Dow traded down 0.37% to 34,617.17 while the Nasdaq fell 0.05% to 34,617.14. The S&P 500 also fell, dropping 0.26% to 4,379.88. Let's look at what has happened in the markets thus far.
In this article: PCRX, CENX, VYGR, SUPN, RFP, ADMS, FLXN, PTGX, HYLN, CIFR
Read
3 Promising Gene Therapy Stocks
Article By: Tarun Chandra, CFA
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Read
Stocks To Trade: ILG, HFC, PCRX
Article By: Ryan Mallory
Thursday, January 18, 2018 4:21 AM EDT
Thursday's stock picks: ILG, HFC and PCRX.
In this article: ILG, HFC, PCRX
Read
Morning Call For Tuesday, March 7
Article By: Jim Van Meerten
Tuesday, March 7, 2017 7:49 AM EDT
Mar E-mini S&Ps (ESH17 -0.18%) this morning are down -0.15% and European stocks are down -0.14% as weakness in metals prices undercuts mining stocks and raw-material producers.
In this article: SIASI, CRM, FRCB, H, WFTLF, PCRX, CASY, DISH, LJPC, HASI, STAY
Read
All Posts

Latest Tweets for $PCRX

No tweets yet!

PARTNER HEADLINES